Twin Tree Management LP Purchases 46,485 Shares of Cardinal Health, Inc. $CAH

Twin Tree Management LP grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 55.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 129,657 shares of the company’s stock after acquiring an additional 46,485 shares during the period. Twin Tree Management LP’s holdings in Cardinal Health were worth $21,782,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Greykasell Wealth Strategies Inc. acquired a new stake in Cardinal Health during the first quarter worth approximately $26,000. Jones Financial Companies Lllp boosted its holdings in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. GW&K Investment Management LLC grew its position in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after buying an additional 144 shares during the period. Garde Capital Inc. bought a new stake in shares of Cardinal Health in the 1st quarter valued at $52,000. Finally, Zions Bancorporation National Association UT bought a new stake in shares of Cardinal Health in the 1st quarter valued at $52,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider directly owned 14,976 shares of the company’s stock, valued at $2,228,728.32. The trade was a 47.41% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Finally, Argus set a $189.00 price objective on Cardinal Health in a research note on Friday, August 22nd. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $166.00.

Cardinal Health Price Performance

CAH opened at $154.11 on Wednesday. Cardinal Health, Inc. has a fifty-two week low of $106.98 and a fifty-two week high of $168.44. The firm has a market capitalization of $36.61 billion, a PE ratio of 23.89, a P/E/G ratio of 1.30 and a beta of 0.71. The company’s 50-day moving average is $151.92 and its 200 day moving average is $151.45.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the company posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s dividend payout ratio is presently 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.